Viewing Study NCT00789828

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2025-12-31 @ 11:23 AM
Study NCT ID: NCT00789828
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2008-11-12
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberous Sclerosis View
None Subependymal Giant Cell Astrocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SEGA View
None Tuberous Sclerosis View
None Subependymal Giant Cell Astrocytoma View
None mTOR View
None RAD001 View
None Mamalian Target Rapamycin View
None Everolimus View
None TSC View